131 related articles for article (PubMed ID: 36828805)
61. Multiple bloodstream infections in pediatric stem cell transplant recipients: A case series.
Grossmann L; Alonso PB; Nelson A; El-Bietar J; Myers KC; Lane A; Andersen H; Haslam D; Jodele S; Davies SM; Dandoy CE
Pediatr Blood Cancer; 2018 Dec; 65(12):e27388. PubMed ID: 30094932
[TBL] [Abstract][Full Text] [Related]
62. The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Satlin MJ; Soave R; Racanelli AC; Shore TB; van Besien K; Jenkins SG; Walsh TJ
Leuk Lymphoma; 2014 Dec; 55(12):2858-65. PubMed ID: 24559288
[TBL] [Abstract][Full Text] [Related]
63. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.
Almyroudis NG; Fuller A; Jakubowski A; Sepkowitz K; Jaffe D; Small TN; Kiehn TE; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2005 Mar; 7(1):11-7. PubMed ID: 15984943
[TBL] [Abstract][Full Text] [Related]
64. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients.
Mullen CA; Nair J; Sandesh S; Chan KW
Bone Marrow Transplant; 2000 Jan; 25(1):59-65. PubMed ID: 10654016
[TBL] [Abstract][Full Text] [Related]
65. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
[TBL] [Abstract][Full Text] [Related]
66. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia.
Tsimberidou AM; Stavroyianni N; Viniou N; Papaioannou M; Tiniakou M; Marinakis T; Skandali A; Sakellari I; Yataganas X;
Cancer; 2003 Apr; 97(7):1721-31. PubMed ID: 12655529
[TBL] [Abstract][Full Text] [Related]
67. Intensive oral care can reduce bloodstream infection with coagulase-negative staphylococci after neutrophil engraftment in allogeneic hematopoietic stem-cell transplantation.
Suwabe T; Fuse K; Katsura K; Soga M; Katagiri T; Shibasaki Y; Narita M; Sone H; Masuko M
Support Care Cancer; 2022 Jan; 30(1):475-485. PubMed ID: 34313857
[TBL] [Abstract][Full Text] [Related]
68. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.
Ulaner GA; Goldman DA; Sauter CS; Migliacci J; Lilienstein J; Gönen M; Schöder H; Moskowitz CH; Zelenetz AD
Radiology; 2015 Nov; 277(2):518-26. PubMed ID: 26035588
[TBL] [Abstract][Full Text] [Related]
69. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
70. Pediatric Invasive Fungal Risk Score in Cancer and Hematopoietic Stem Cell Transplantation Patients With Febrile Neutropenia.
Alali M; Giurcanu M; Elmuti L; Kumar M
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e334-e342. PubMed ID: 34224520
[TBL] [Abstract][Full Text] [Related]
71. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
72. Monocenter study on epidemiology, outcomes, and risk factors of infections in recipients of 166 allogeneic stem cell transplantations during 1 year.
Samek M; Iversen K; Belmar Campos C; Berneking L; Langebrake C; Wolschke C; Ayuk F; Kröger N; Christopeit M
Eur J Haematol; 2020 Aug; 105(2):126-137. PubMed ID: 32236988
[TBL] [Abstract][Full Text] [Related]
73. Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis.
ElGohary G; Toor AA; Gergis U
Bone Marrow Transplant; 2023 Jan; 58(1):1-9. PubMed ID: 36284212
[TBL] [Abstract][Full Text] [Related]
74. Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.
Rowe RG; Guo D; Lee M; Margossian S; London WB; Lehmann L
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1275-1283. PubMed ID: 27090959
[TBL] [Abstract][Full Text] [Related]
75. Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy.
Winters AC; Bosma G; Abbott D; Minhajuddin M; Jordan C; Pollyea DA; Gutman JA
Transplant Cell Ther; 2022 Oct; 28(10):694.e1-694.e9. PubMed ID: 35902048
[TBL] [Abstract][Full Text] [Related]
76. Standardized Semi-structured Psychosocial Evaluation before Hematopoietic Stem Cell Transplantation Predicts Patient Adherence to Post-Transplant Regimen.
Mishkin AD; Shapiro PA; Reshef R; Lopez-Pintado S; Mapara MY
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2222-2227. PubMed ID: 31247314
[TBL] [Abstract][Full Text] [Related]
77. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
78. High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: a single-centre experience.
Olavarria E; Kanfer E; Szydlo R; O'Brien S; Craddock C; Apperley J; Goldman J
Br J Haematol; 2000 Mar; 108(4):769-77. PubMed ID: 10792282
[TBL] [Abstract][Full Text] [Related]
79. Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation.
Roy V; Ali LI; Selby GB
Am J Hematol; 2000 Jul; 64(3):170-4. PubMed ID: 10861811
[TBL] [Abstract][Full Text] [Related]
80. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Ljungman P; Ward KN; Crooks BN; Parker A; Martino R; Shaw PJ; Brinch L; Brune M; De La Camara R; Dekker A; Pauksen K; Russell N; Schwarer AP; Cordonnier C
Bone Marrow Transplant; 2001 Sep; 28(5):479-84. PubMed ID: 11593321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
